DS-2741a

N/A

Report date: 2024/11/18 16:20:02

Base Information

Drug NameDS-2741a
Drug Alias NameDS-2741a
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCalcium release-activated calcium channel protein 1 blockers
TargetsCalcium release-activated calcium channel protein 1
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A